SARS-Cov 2, un virus para reumatólogos
Contenido principal del artículo
Barra lateral del artículo
Publicado
2020 octubre 30
Guillermo Sequera
Cómo citar
1.
Sequera G. SARS-Cov 2, un virus para reumatólogos. Rev. parag. reumatol. [Internet]. 2020 Oct. 30 [cited 2026 Oct. 25];6(2):48-9. Available from: https://www.revista.spr.org.py/index.php/spr/article/view/124
Descargas
Los datos de descarga aún no están disponibles.
Detalles del artículo
References
(1) Cohen J. From mice to monkeys, animals studied for coronavirus answers. Science (80-) [Internet]. 2020 Apr 17;368(6488):221 LP-222. Available from: http://science.sciencemag.org/content/368/6488/221.abstract
(2) Morris SB, Schwartz NG, Patel P, Abbo L, Beauchamps L, Balan S, et al. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection - United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep. 2020 Oct;69(40):1450–6.
(3) Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science (80- ) [Internet]. 2020 Oct 23;370(6515):eabd4570. Available from: http://science.sciencemag.org/content/370/6515/eabd4570.abstract
(4) Cajamarca-Baron J, Guavita-Navarro D, Buitrago-Bohorquez J, Gallego-Cardona L, Navas A, Cubides H, et al. SARS-CoV-2 (COVID-19) in Patients with some Degree of Immunosuppression. Reumatología Clinica 2020 Oct 16. doi: 10.1016/j.reumae.2020.08.001
(5) Michaud K, Wipfler K, Shaw Y, Simon TA, Cornish A, England BR, et al. Experiences of Patients With Rheumatic Diseases in the United States During Early Days of the COVID-19 Pandemic. ACR open Rheumatol. 2020 Jun;2(6):335–43.
(6) Romão VC, Cordeiro I, Macieira C, Oliveira-Ramos F, Romeu JC, Rosa CM, et al. Rheumatology practice amidst the COVID-19 pandemic: a pragmatic view. RMD open. 2020 Jun;6(2).
(2) Morris SB, Schwartz NG, Patel P, Abbo L, Beauchamps L, Balan S, et al. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection - United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep. 2020 Oct;69(40):1450–6.
(3) Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J, et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science (80- ) [Internet]. 2020 Oct 23;370(6515):eabd4570. Available from: http://science.sciencemag.org/content/370/6515/eabd4570.abstract
(4) Cajamarca-Baron J, Guavita-Navarro D, Buitrago-Bohorquez J, Gallego-Cardona L, Navas A, Cubides H, et al. SARS-CoV-2 (COVID-19) in Patients with some Degree of Immunosuppression. Reumatología Clinica 2020 Oct 16. doi: 10.1016/j.reumae.2020.08.001
(5) Michaud K, Wipfler K, Shaw Y, Simon TA, Cornish A, England BR, et al. Experiences of Patients With Rheumatic Diseases in the United States During Early Days of the COVID-19 Pandemic. ACR open Rheumatol. 2020 Jun;2(6):335–43.
(6) Romão VC, Cordeiro I, Macieira C, Oliveira-Ramos F, Romeu JC, Rosa CM, et al. Rheumatology practice amidst the COVID-19 pandemic: a pragmatic view. RMD open. 2020 Jun;6(2).
Sección
EDITORIAL

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Cómo citar
1.
Sequera G. SARS-Cov 2, un virus para reumatólogos. Rev. parag. reumatol. [Internet]. 2020 Oct. 30 [cited 2026 Oct. 25];6(2):48-9. Available from: https://www.revista.spr.org.py/index.php/spr/article/view/124
https://orcid.org/0000-0002-7707-1363